Bill
A 4015
Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.
2024-2025 Regular Session
Introduced by Dave Bailey and 4 co-sponsors
New Jersey pharmacies must inform insulin patients about manufacturer assistance programs to reduce medication costs and improve treatment access.
Substituted by S2886 (1R)